87 related articles for article (PubMed ID: 7577748)
1. Immunohistochemical analysis of dendritic/Langerhans cells in thyroid carcinomas.
Yamakawa M; Yamada K; Orui H; Tsuge T; Ogata T; Dobashi M; Imai Y
Anal Cell Pathol; 1995 Jun; 8(4):331-43. PubMed ID: 7577748
[TBL] [Abstract][Full Text] [Related]
2. Association of CD1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: a cytologic and immunocytochemical evaluation.
Pusztaszeri MP; Sadow PM; Faquin WC
Cancer Cytopathol; 2013 Apr; 121(4):206-13. PubMed ID: 23042745
[TBL] [Abstract][Full Text] [Related]
3. Recruitment of dendritic cells in oral lichen planus.
Santoro A; Majorana A; Roversi L; Gentili F; Marrelli S; Vermi W; Bardellini E; Sapelli P; Facchetti F
J Pathol; 2005 Mar; 205(4):426-34. PubMed ID: 15714455
[TBL] [Abstract][Full Text] [Related]
4. Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha, and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma.
Zijlmans HJ; Fleuren GJ; Baelde HJ; Eilers PH; Kenter GG; Gorter A
Cancer; 2007 Feb; 109(3):556-65. PubMed ID: 17177206
[TBL] [Abstract][Full Text] [Related]
5. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
[TBL] [Abstract][Full Text] [Related]
6. Characterization of dendritic cells in differentiated thyroid cancer.
Tsuge K; Takeda H; Kawada S; Maeda K; Yamakawa M
J Pathol; 2005 Apr; 205(5):565-76. PubMed ID: 15714595
[TBL] [Abstract][Full Text] [Related]
7. [HBME-1 immunostaining in thyroid pathology].
Rigau V; Martel B; Evrard C; Rousselot P; Galateau-Salle F
Ann Pathol; 2001 Feb; 21(1):15-20. PubMed ID: 11223556
[TBL] [Abstract][Full Text] [Related]
8. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
9. Blood group antigens in differentiated thyroid neoplasms.
González-Cámpora R; García-Sanatana JA; Jordà i Heras MM; Salaverri CO; Vázquez-Ramírez FJ; Argueta-Manzano OE; Galera-Davidson H
Arch Pathol Lab Med; 1998 Nov; 122(11):957-65. PubMed ID: 9822123
[TBL] [Abstract][Full Text] [Related]
10. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
[TBL] [Abstract][Full Text] [Related]
12. [Poorly differentiated carcinoma of the thyroid--immunohistochemical evaluation of p53 and p27 protein expression].
Wierzchowski W; Szybiński P; Nowak W; Nowak K; Szybiński Z; Buziak-Bereza M; Stachura J
Wiad Lek; 2001; 54 Suppl 1():79-87. PubMed ID: 12182066
[TBL] [Abstract][Full Text] [Related]
13. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
[TBL] [Abstract][Full Text] [Related]
14. The maturation-dependent production of interleukin-16 is impaired in monocyte-derived dendritic cells from atopic dermatitis patients but is restored by inflammatory cytokines TNF-alpha and IL-1beta.
Reich K; Hugo S; Middel P; Blaschke V; Heine A; Neumann C
Exp Dermatol; 2004 Dec; 13(12):740-7. PubMed ID: 15560757
[TBL] [Abstract][Full Text] [Related]
15. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
Canque B; Camus S; Yagello M; Gluckman JC
Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.
Kamoshida S; Ogane N; Yasuda M; Muramatsu T; Bessho T; Kajiwara H; Osamura RY
Mod Pathol; 2000 Jul; 13(7):736-41. PubMed ID: 10912932
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation.
Kaliński P; Schuitemaker JH; Hilkens CM; Kapsenberg ML
J Immunol; 1998 Sep; 161(6):2804-9. PubMed ID: 9743339
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 is a presurgical marker of human thyroid carcinoma.
Orlandi F; Saggiorato E; Pivano G; Puligheddu B; Termine A; Cappia S; De Giuli P; Angeli A
Cancer Res; 1998 Jul; 58(14):3015-20. PubMed ID: 9679965
[TBL] [Abstract][Full Text] [Related]
19. Beta- and gamma-catenin expression in thyroid carcinomas.
Cerrato A; Fulciniti F; Avallone A; Benincasa G; Palombini L; Grieco M
J Pathol; 1998 Jul; 185(3):267-72. PubMed ID: 9771480
[TBL] [Abstract][Full Text] [Related]
20. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
